Literature DB >> 30118845

Tim-4 promotes the growth of colorectal cancer by activating angiogenesis and recruiting tumor-associated macrophages via the PI3K/AKT/mTOR signaling pathway.

Xiao Tan1, Zhongqiang Zhang2, Hongliang Yao2, Liangfang Shen3.   

Abstract

T-cell immunoglobulin domain and mucin domain-4 (Tim-4) is overexpressed in several tumors and is correlated with enhanced tumor development and metastasis. In this study, we investigated the physiological alterations and molecular events related to Tim-4 overexpression in a mouse model of colorectal cancer (CRC). In the current study, we observed that Tim-4 is upregulated in CRC tissues compared with neighboring normal tissues. In addition, statistical analysis revealed that elevated Tim-4 expression was strongly linked to distant metastasis, TNM stage and reduced overall survival duration in CRC patients. An orthotopic model was employed to explore the function of Tim-4 in CRC development through the implantation of Tim-4-overexpressing CT26 murine colon adenocarcinoma cells. It was observed that Tim-4 overexpression considerably enhanced CRC tumorigenesis in vivo and promoted angiogenesis through the upregulation of vascular endothelial growth factor (VEGF). In CT26 cells, Tim-4 overexpression increased the aldehyde dehydrogenase-1 (ALDH1) level, indicating an increase in cancer stem cell (CSC)-like properties. Furthermore, we determined that Tim-4 activates PI3K/AKT/mTOR signaling in CRC cells. Tim-4-overexpressing cancer cells recruited tumor-associated macrophages (TAMs), thereby accelerating cancer development. Therefore, our results strongly indicate that Tim-4 overexpression promotes proliferation and tumor stroma remodeling in CRC. PI3K/AKT/mTOR activation might be crucial in Tim-4-linked tumor development. This finding might offer a new strategy for therapeutic intervention.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CRC; Macrophages; Stem-like cells; Tim-4; Tumor growth

Mesh:

Substances:

Year:  2018        PMID: 30118845     DOI: 10.1016/j.canlet.2018.08.012

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  32 in total

1.  DFNA5 inhibits colorectal cancer proliferation by suppressing the mTORC1/2 signaling pathways via upregulation of DEPTOR.

Authors:  Jing Guo; Junhui Yu; Mingchao Mu; Zilu Chen; Zhengshui Xu; Chenye Zhao; Kui Yang; Jianbao Zheng; Xiao Qin; Wei Zhao; Xuejun Sun
Journal:  Cell Cycle       Date:  2022-08-03       Impact factor: 5.173

2.  Cardamonin suppresses pro-tumor function of macrophages by decreasing M2 polarization on ovarian cancer cells via mTOR inhibition.

Authors:  Huajiao Chen; Sheng Huang; Peiguang Niu; Yanting Zhu; Jintuo Zhou; Li Jiang; Danyun Li; Daohua Shi
Journal:  Mol Ther Oncolytics       Date:  2022-06-25       Impact factor: 6.311

3.  Pharmacological Inhibition of Endogenous Hydrogen Sulfide Attenuates Breast Cancer Progression.

Authors:  Nazeer Hussain Khan; Di Wang; Wenkang Wang; Muhammad Shahid; Saadullah Khattak; Ebenezeri Erasto Ngowi; Muhammad Sarfraz; Xin-Ying Ji; Chun-Yang Zhang; Dong-Dong Wu
Journal:  Molecules       Date:  2022-06-23       Impact factor: 4.927

Review 4.  Chloride intracellular channel 1 promotes esophageal squamous cell carcinoma proliferation via mTOR signalling.

Authors:  Huiwu Geng; Cheng Feng; Zhangran Sun; Xu Fan; Yiqing Xie; Jinghua Gu; Libin Fan; Gang Liu; Chao Li; Rick F Thorne; Xu Dong Zhang; Xinying Li; Xiaoying Liu
Journal:  Transl Oncol       Date:  2022-10-14       Impact factor: 4.803

5.  TRIM24 promotes colorectal cancer cell progression via the Wnt/β-catenin signaling pathway activation.

Authors:  Hong Tian; Hongmei Zhao; Bo Qu; Xiaoli Chu; Xing Xin; Qingwei Zhang; Weizhou Li; Shida Yang
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

Review 6.  Lifting the innate immune barriers to antitumor immunity.

Authors:  Carla V Rothlin; Sourav Ghosh
Journal:  J Immunother Cancer       Date:  2020-04       Impact factor: 13.751

7.  Elevated CD163+/CD68+ Ratio at Tumor Invasive Front is Closely Associated with Aggressive Phenotype and Poor Prognosis in Colorectal Cancer.

Authors:  Chaogang Yang; Chen Wei; Shuyi Wang; Dongdong Shi; Chunxiao Zhang; Xiaobin Lin; Rongzhang Dou; Bin Xiong
Journal:  Int J Biol Sci       Date:  2019-03-10       Impact factor: 6.580

8.  PLCA8 suppresses breast cancer apoptosis by activating the PI3k/AKT/NF-κB pathway.

Authors:  Misha Mao; Yongxia Chen; Yunlu Jia; Jingjing Yang; Qun Wei; Zhaoqing Li; Lini Chen; Cong Chen; Linbo Wang
Journal:  J Cell Mol Med       Date:  2019-08-26       Impact factor: 5.310

Review 9.  Emerging Perspective: Role of Increased ROS and Redox Imbalance in Skin Carcinogenesis.

Authors:  Dehai Xian; Rui Lai; Jing Song; Xia Xiong; Jianqiao Zhong
Journal:  Oxid Med Cell Longev       Date:  2019-09-16       Impact factor: 6.543

10.  Exosomal MALAT1 sponges miR-26a/26b to promote the invasion and metastasis of colorectal cancer via FUT4 enhanced fucosylation and PI3K/Akt pathway.

Authors:  Jingchao Xu; Yang Xiao; Bing Liu; Shimeng Pan; Qianqian Liu; Yujia Shan; Shuangda Li; Yu Qi; Yiran Huang; Li Jia
Journal:  J Exp Clin Cancer Res       Date:  2020-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.